Please sign in to follow a disease.
Can early feeding after esophagus surgery cut infection risk?
NCT ID NCT05892263
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether starting feeding through a tube soon after esophageal cancer surgery can lower infection rates and help the gut work again. 70 adults who had their esophagus removed took part. The goal was to see if early feeding reduces complications like leaks and infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
70 people
The number who actually took part.
- Started
-
Nov 2022
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Esophagectomy * Esophagectomy & reconstruction * Esophagotomy * Esophageal reconstruction-with gastric tube * Esophageal reconstruction-with colon * Esophageal reconstruction with small intestine Exclusion Criteria: * Gastrointestinal perforation * Postoperative hemorrhage * Intestinal obstruction * Shock
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Early-feeding are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Taiwan University Hospital
Taipei, Taiwan, 100, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood proteins may predict who beats esophageal cancer with chemoradiation
- New Antibody-Drug conjugate put to the test against Hard-to-Treat cancers
- Can a direct hit to tumors make immunotherapy work better?
- New antibody aims to preserve immune checkpoint while fighting cancer
- Can a guided missile for chemo hit tumors harder and spare healthy tissue?
- Can a new drug shrink tumors that resist standard care?